Evicenter
MarkdownMedical informationP&T meetings
AD109 (aroxybutynin-atomoxetine)

Obstructive sleep apnea

Also known as Oxnimbi
Manufacturer
Apnimed
Launch
Not announced
Last updated
183 sources

Product information and disease descriptionPlace of product in therapyDisease description

Definition and etiology

9 evidence topics · 5 sources

Obesity as a risk factor: share of adults with OSA who have obesity, AHI of 5 or more with 4% desaturation hypopnea rule (individual participant data meta-analysis with Apnimed authors)